CLOs on the Move

La Jolla Institute for Immunology

www.lji.org

 
La Jolla Institute for Immunology is a non-profit research organization located in La Jolla, California.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.lji.org
  • 9420, Athena Circle
    San Diego, CA USA 92037
  • Phone: 858.752.6500

Executives

Name Title Contact Details

Similar Companies

Arthur D. Little

Arthur D. Little is a Boston, MA-based company in the Business Services sector.

Point To Point Communications

Point To Point Communications is a Olathe, KS-based company in the Business Services sector.

DESA

DESA is a Columbia, SC-based company in the Business Services sector.

Hollander Consultants

Hollander Consultants is a Portland, OR-based company in the Business Services sector.

The Calida Group

The Calida Group is a leading developer, investor, and operator of multifamily real estate properties in the western United States. Founded in 2007 by Douglas Eisner and Eric Cohen, the principals have developed or acquired more than 16,000 multifamily units, and its senior management combines over 100 years of real estate experience. Calida invests roughly $1 billion annually across three primary strategies (Development, Value-Add Acquisitions and Core-Plus Acquisitions) on behalf of a series of discretionary commingled funds serving the family office and ultra-high net worth communities, as well as forming partnerships with many of the nation`s largest financial institutions. Calida begins with strategic and creative deal sourcing methods to identify investment opportunities that are often completely off market or otherwise less competitively advertised. Then, by leveraging the firm`s lifestyle-oriented design capabilities and operational expertise, Calida tailors unique business plans for each asset. Finally, by meticulously implementing these business plans while managing construction risk, conservatively financing each property and employing thoughtful tax planning, Calida is able to create superior investment opportunities with lower risk than would typically be expected in deals of similar return profiles.